Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2099) 2099
science & technology (1771) 1771
life sciences & biomedicine (1741) 1741
male (1351) 1351
mucormycosis (1334) 1334
female (954) 954
mucormycosis - microbiology (872) 872
infectious diseases (831) 831
mucormycosis - diagnosis (818) 818
middle aged (816) 816
adult (722) 722
antifungal agents - therapeutic use (674) 674
mucormycosis - drug therapy (643) 643
biological and medical sciences (625) 625
medical sciences (586) 586
microbiology (519) 519
mycoses (502) 502
mucormycosis - pathology (490) 490
amphotericin b - therapeutic use (468) 468
mucormycosis - complications (468) 468
aged (447) 447
mycology (386) 386
fatal outcome (340) 340
human mycoses (336) 336
immunocompromised host (319) 319
mucormycosis - etiology (319) 319
animals (292) 292
mucorales - isolation & purification (283) 283
mucormycosis - therapy (276) 276
zygomycosis (274) 274
health aspects (273) 273
fungi (248) 248
adolescent (247) 247
immunology (241) 241
amphotericin b (237) 237
abridged index medicus (233) 233
risk factors (232) 232
rhizopus - isolation & purification (231) 231
mucormycosis - surgery (225) 225
treatment outcome (224) 224
tomography, x-ray computed (223) 223
surgery (222) 222
antifungal agents (219) 219
care and treatment (210) 210
diagnosis (206) 206
fungal infections (203) 203
dermatology (200) 200
infections (197) 197
mortality (197) 197
child (178) 178
debridement (177) 177
transplantation (177) 177
aspergillosis (169) 169
rhizopus (168) 168
mucormycosis - epidemiology (167) 167
diabetes (161) 161
diagnosis, differential (159) 159
tropical mycoses (159) 159
phycomycoses (158) 158
brain diseases - microbiology (156) 156
antifungal agents - administration & dosage (153) 153
retrospective studies (153) 153
triazoles - therapeutic use (144) 144
orbital diseases - microbiology (143) 143
young adult (139) 139
biopsy (134) 134
mucorales (132) 132
nose diseases - microbiology (130) 130
mucormycosis - veterinary (128) 128
amphotericin b - administration & dosage (126) 126
research (126) 126
combined modality therapy (122) 122
general & internal medicine (122) 122
patients (121) 121
diabetes mellitus (118) 118
hematology (117) 117
magnetic resonance imaging (117) 117
veterinary sciences (116) 116
infection (115) 115
mucor - isolation & purification (114) 114
mucormycosis - immunology (113) 113
posaconazole (113) 113
lung diseases, fungal - microbiology (112) 112
life sciences (111) 111
mucormycosis - diagnostic imaging (110) 110
case report (109) 109
dermatomycoses - microbiology (107) 107
pharmacology & pharmacy (107) 107
sinusitis - microbiology (106) 106
antiparasitic agents (99) 99
child, preschool (98) 98
epidemiology (97) 97
mice (97) 97
paranasal sinus diseases - microbiology (95) 95
pediatrics (94) 94
medicine, general & internal (92) 92
analysis (91) 91
medicine & public health (90) 90
pathology (90) 90
case studies (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2577) 2577
Spanish (74) 74
French (72) 72
German (65) 65
Japanese (20) 20
Chinese (10) 10
Italian (8) 8
Portuguese (7) 7
Russian (7) 7
Czech (4) 4
Dutch (3) 3
Hungarian (3) 3
Turkish (3) 3
Korean (2) 2
Bulgarian (1) 1
Danish (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
by F. Lanternier and E. Dannaoui and G. Morizot and C. Elie and D. Garcia-Hermoso and M. Huerre and D. Bitar and F. Dromer and O. Lortholary and French Mycosis Study Grp and French Mycosis Study Group and the French Mycosis Study Group
Clinical infectious diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue suppl_1, pp. S35 - S43
Mucormycosis | Diabetes mellitus | Hematologic neoplasms | Mortality | Infections | Transplantation | Fungal infections | Diabetes | Epidemiology | Zygomycosis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hematologic Neoplasms - microbiology | Wounds and Injuries - microbiology | Lung - microbiology | Dermatomycoses - drug therapy | Prognosis | Humans | Middle Aged | Male | Data Collection | Cerebellar Diseases - surgery | Antifungal Agents - therapeutic use | Young Adult | Cerebellar Diseases - complications | Cerebellar Diseases - pathology | Adult | Female | Cerebellar Diseases - microbiology | Retrospective Studies | Hematologic Neoplasms - complications | Mucormycosis - drug therapy | Child | Rhizopus - pathogenicity | Dermatomycoses - complications | France - epidemiology | Lung - pathology | Mucormycosis - epidemiology | Wounds and Injuries - surgery | Risk Factors | Proportional Hazards Models | Wounds and Injuries - complications | Treatment Outcome | Diabetes Mellitus - microbiology | Mucormycosis - complications | Mucormycosis - microbiology | Adolescent | Survival Analysis | Aged | Dermatomycoses - microbiology | Amphotericin B - therapeutic use | Fungi | Skin diseases | Regression analysis | Risk factors | Nonnative species | Index Medicus | Hematologic Neoplasms | Rhizopus | Lung | Life Sciences | Antifungal Agents | France | Cerebellar Diseases | Mycology | Diabetes Mellitus | Dermatomycoses | Microbiology and Parasitology | Wounds and Injuries | Amphotericin B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Epidemiology and Clinical Manifestations of Mucormycosis
by George Petrikkos and Anna Skiada and Olivier Lortholary and Emmanuel Roilides and Thomas J. Walsh and Dimitrios P. Kontoyiannis
Clinical infectious diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue suppl_1, pp. S23 - S34
Mucormycosis | Diabetes complications | Diabetes mellitus | Predisposing factors | Infections | Transplantation | Fungal infections | Diabetes | Epidemiology | Zygomycosis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hematologic Neoplasms - microbiology | Diabetes Complications - microbiology | Mucormycosis - epidemiology | Communicable Diseases, Emerging - microbiology | Humans | Risk Factors | Rheumatic Diseases - microbiology | Mucorales - pathogenicity | Communicable Diseases, Emerging - epidemiology | Cross Infection - complications | Mucormycosis - complications | Adrenal Cortex Hormones - adverse effects | Communicable Diseases, Emerging - complications | Mucormycosis - classification | Mucormycosis - microbiology | Cross Infection - microbiology | Organ Transplantation - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Rheumatic Diseases - complications | Hematologic Neoplasms - complications | Fungi | Transplants & implants | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Healthcare-Associated Mucormycosis
by Blandine Rammaert and Fanny Lanternier and Jean-Ralph Zahar and Eric Dannaoui and Marie-Elisabeth Bougnoux and Marc Lecuit and Olivier Lortholary
Clinical infectious diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue suppl_1, pp. S44 - S54
Mucormycosis | Mucorales | Rhizopus | Diabetes mellitus | Predisposing factors | Infections | Transplantation | Fungal infections | Mucor | Zygomycosis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Diabetes Mellitus - pathology | Lung - microbiology | Humans | Male | Equipment Contamination | Gastrointestinal Tract - pathology | Antifungal Agents - therapeutic use | Cross Infection - transmission | Cross Infection - pathology | Disease Outbreaks | Mucormycosis - pathology | Female | Dermatomycoses - pathology | Mucormycosis - drug therapy | Child | Rhizopus - pathogenicity | Lung - pathology | Mucormycosis - transmission | Risk Factors | Gastrointestinal Tract - microbiology | Treatment Outcome | Bandages - microbiology | Cross Infection - drug therapy | Diabetes Mellitus - microbiology | Mucormycosis - microbiology | Cross Infection - microbiology | Organ Transplantation - adverse effects | Dermatomycoses - microbiology | Fungi | Skin | Transplants & implants | Nonnative species | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Population-based analysis of invasive fungal infections, France, 2001-2010
by Bitar, Dounia and Lortholary, Olivier and Le Strat, Yann and Nicolau, Javier and Coignard, Bruno and Tattevin, Pierre and Che, Didier and Dromer, Françoise
Emerging infectious diseases, ISSN 1080-6040, 2014, Volume 20, Issue 7, pp. 1149 - 1155
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Hematologic Neoplasms - microbiology | Mycoses - epidemiology | Cryptococcosis - microbiology | Hematologic Neoplasms - mortality | Humans | Middle Aged | Mycoses - microbiology | Male | Pneumocystis carinii | Candidemia - mortality | Hematologic Neoplasms - epidemiology | Aspergillosis - epidemiology | HIV Infections - microbiology | Pneumonia, Pneumocystis - epidemiology | Aspergillosis - mortality | Adult | Female | Candidemia - microbiology | France - epidemiology | Hospital Mortality | Risk Factors | Candidemia - epidemiology | Pneumonia, Pneumocystis - mortality | Aspergillosis - microbiology | Cryptococcosis - mortality | Cryptococcosis - epidemiology | Aged | Mycoses - mortality | Pneumonia, Pneumocystis - microbiology | Pneumonia | Chronic kidney failure | Bacterial pneumonia | Analysis | Mortality | AIDS (Disease) | Mycoses | HIV patients | France | Index Medicus | Invasive mycosis | candidemia | mucormycosis | cryptococcosis | aspergillosis | Pneumocystis jirovecii
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Burden of fungal infections in Qatar
by Taj‐Aldeen, Saad J and Chandra, Prem and Denning, David W
Mycoses, ISSN 0933-7407, 10/2015, Volume 58, Issue S5, pp. 51 - 57
Cryptococcus meningitis | candidiasis | Burden of fungal infections | mucormycosis | aspergillosis | Pneumocystis pneumonia | Mucormycosis | Candidiasis | Aspergillosis | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Mycoses - epidemiology | Aspergillosis, Allergic Bronchopulmonary - microbiology | HIV Infections - epidemiology | Humans | Middle Aged | Vaginitis - microbiology | Cost of Illness | Mycoses - microbiology | Male | Aspergillosis - epidemiology | Meningitis, Cryptococcal - microbiology | Incidence | Young Adult | Pneumonia, Pneumocystis - epidemiology | Adult | Female | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Candidemia - microbiology | Mucormycosis - epidemiology | Fusariosis - epidemiology | Candidemia - epidemiology | Pulmonary Aspergillosis - microbiology | Qatar - epidemiology | Mucormycosis - microbiology | Pulmonary Aspergillosis - epidemiology | AIDS-Related Opportunistic Infections - epidemiology | Candida | Meningitis, Cryptococcal - epidemiology | Adolescent | Aspergillosis - microbiology | Pneumonia, Pneumocystis - microbiology | Vaginitis - epidemiology | Fusariosis - microbiology | Mycoses | Meningitis | Pneumonia | Health aspects | Bacterial pneumonia | Antifungal agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The burden of serious fungal diseases in Russia
by Klimko, N and Kozlova, Y and Khostelidi, S and Shadrivova, O and Borzova, Y and Burygina, E and Vasilieva, N and Denning, D. W
Mycoses, ISSN 0933-7407, 10/2015, Volume 58, Issue S5, pp. 58 - 62
cryptococcal meningitis | candidiasis | mucormycosis | aspergillosis | fungal infections | Russia | Mucormycosis | Candidiasis | Cryptococcal meningitis | Fungal infections | Aspergillosis | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Mycoses - epidemiology | Candidiasis, Vulvovaginal - epidemiology | Prevalence | Aspergillosis, Allergic Bronchopulmonary - microbiology | HIV Infections - epidemiology | Humans | Candidiasis - epidemiology | Cost of Illness | Mycoses - microbiology | Male | Aspergillosis - epidemiology | Candidiasis - microbiology | Meningitis, Cryptococcal - microbiology | Incidence | HIV Infections - microbiology | Pneumonia, Pneumocystis - epidemiology | Adult | Female | Russia - epidemiology | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Mucormycosis - epidemiology | Tinea Capitis - epidemiology | Tinea Capitis - microbiology | Mucormycosis - microbiology | AIDS-Related Opportunistic Infections - epidemiology | Meningitis, Cryptococcal - epidemiology | Aspergillosis - microbiology | Mycoses - complications | Candidiasis, Vulvovaginal - microbiology | Pneumonia, Pneumocystis - microbiology | Mycoses | Meningitis | Pneumonia | Bacterial pneumonia | Antifungal agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7.